NCT05525169 Study of the Impact of Exposure to Outdoor and Indoor Pollutants in Patients With Asthma
| NCT ID | NCT05525169 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nantes University Hospital |
| Condition | Asthma |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2022-11-15 |
| Primary Completion | 2026-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2022-11-15 with a primary completion date of 2026-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project is to measure exposure to outdoor and indoor air pollutants in asthma patients in order to show a possible association between variation in pollutant exposure and the occurrence of exacerbations in these patients
Eligibility Criteria
Inclusion Criteria: * Patient over 18 years of age, * Patient with a confirmed diagnosis of asthma for at least 12 months as defined by the investigator, * Patient with at least 4 asthma exacerbations in the last year * Patient sleeping at least 6 nights per week in the same home Exclusion Criteria: * Patient who is an active smoker or living with an active smoker, * Patient with a diagnosis of COPD, ABPA or associated pulmonary fibrosis, * Patient with an asthma exacerbation within 15 days prior to the inclusion visit, * Patient with known occupational exposure, * Patient living in a dwelling that does not allow the installation of sensors (inability to connect the sensor to the power supply, no location for the outdoor sensor...) * Patient who plans to move in the next 6 months, * Patient with a life expectancy of less than 6 months, * Patient who has someone living in their household also included in EXAP, * Patient who lives in an apartment and does not have a balcony or space for the outdoor sensor, * Pregnant or breastfeeding women,
Contact & Investigator
François-Xavier Blanc, PU-PH
PRINCIPAL INVESTIGATOR
Nantes University Hospital
Frequently Asked Questions
Who can join the NCT05525169 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05525169 currently recruiting?
Yes, NCT05525169 is actively recruiting participants. Contact the research team at xavier.blanc@chu-nantes.fr for enrollment information.
Where is the NCT05525169 trial being conducted?
This trial is being conducted at Nantes, France.
Who is sponsoring the NCT05525169 clinical trial?
NCT05525169 is sponsored by Nantes University Hospital. The principal investigator is François-Xavier Blanc, PU-PH at Nantes University Hospital. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.